Randomization & IWRS Plan (OBX319-301)
π Part of the OBX-319 Regulatory Dossier β Reader's Guide. This article shows the live document; edits to the source appear here automatically.
This is a mock / simulation document, made for a portfolio and for learning. The drug (GLPI-103), the sponsor, the people, and the data are all fictional. It is not a real regulatory submission and has no clinical, legal, or regulatory standing. What is real is the shape of the thing β the document structure, the standards it follows, and the analysis methods; the content inside is illustrative.
What it is. Randomization & IWRS Plan (OBX319-301)
Why it exists. An operational trial document describing how the trial is run.
How it is produced here. It is an operational trial document β a plan, charter, or template of the kind kept in the Trial Master File. It describes how the trial is run, rather than reporting the trial's results.
Format & governing standard. β
Randomization & IWRS Plan (OBX319-301)
Document ID: TMF-012
Version: 1.0
Change History: 1.0 β Initial issue.
Standard(s): ICH E6(R3) / E9
Randomization & IWRS Plan β OBX319-301
The randomization specification for OBX319-301: allocation 1:1:1, stratification factors, block structure, the IWRS/IRT workflow for assignment and drug supply, and emergency unblinding. Generated under access control and held independent of the study team. ICH E6(R3); E9.
No comments yet. Be the first to say something!